1995
DOI: 10.1177/096032719501400707
|View full text |Cite
|
Sign up to set email alerts
|

Inter-subject variability in the metabolism of aluminium following intravenous injection as citrate

Abstract: 1 Six healthy male volunteers received intravenous injec tions of 26Al as citrate. Accelerator mass spectrometry and γ-ray spectrometry were used to determine levels of the tracer in blood and excreta at times up to 5-6 d. 2 There was a rapid clearance from blood (mean 2% of injection remaining after 1 d) and major loss in urine (59% up to 1 d), but 27 ± 7 (s.d.)% was retained in the body at 5 d. Faecal excretion was negligible (1% up to 5 d). 3… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
36
0

Year Published

1999
1999
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(38 citation statements)
references
References 5 publications
1
36
0
Order By: Relevance
“…Within the first day of receiving a single injection of 26 Al citrate, approximately 59% of the dose was excreted in the urine of six subjects; 72 and 1.2% was excreted in the urine and feces, respectively, during the first 5 days . At the end of 5 days, it was estimated that 27% of the dose was retained in the body Talbot et al 1995). When 26 Al levels were monitored more than 3 years after a single subject received the injection, a half-life of approximately 7 years was calculated .…”
Section: Elimination and Excretionmentioning
confidence: 99%
“…Within the first day of receiving a single injection of 26 Al citrate, approximately 59% of the dose was excreted in the urine of six subjects; 72 and 1.2% was excreted in the urine and feces, respectively, during the first 5 days . At the end of 5 days, it was estimated that 27% of the dose was retained in the body Talbot et al 1995). When 26 Al levels were monitored more than 3 years after a single subject received the injection, a half-life of approximately 7 years was calculated .…”
Section: Elimination and Excretionmentioning
confidence: 99%
“…However, aluminum adjuvants are ineffective in inducing a cell-mediated immune response; are inactivated by freezing; can have a detrimental effect on the stability of vaccine antigens; and are associated with local adverse vaccine reactions. In addition, aluminum is not biodegradable, and most of it is excreted via the kidneys and sweat glands [5,6]. A variety of materials has been tested as vaccine adjuvants with variable degrees of success, and only a few alternatives to aluminum adjuvants have found their way into licensed vaccines [7].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, aluminum is not biodegradable. 3,4 At the same time, natural polymers such as polysaccharides have been widely studied as safe and potent alternative adjuvants, which can effectively strengthen the primary and the adaptive immune responses, and as a consequence increase the efficacy of vaccines. 5,6 Rehmannia glutinosa polysaccharide (RGP), one of the active components of R. glutinosa, was shown to exert strong immunomodulatory properties.…”
Section: Introductionmentioning
confidence: 99%